Oncology Business Management | Specialty

Could Healthcare Reform Speed Molecular Medicine Adoption?

November 21st 2014

Over the past decade drug development in cancer has shifted to an increasingly gene target–based approach.

FDA Approves Bevacizumab for Recurrent Ovarian Cancer

November 14th 2014

The FDA has approved bevacizumab in combination with chemotherapy for patients with recurrent platinum-resistant ovarian cancer.

ASCO to Establish New Practice Management Department

November 14th 2014

ASCO members who need hands-on assistance in practice management, quality care assessment and improvement, and efficiency and business intelligence will be able to contact a soon to be established clinical affairs department at the organization.

Latest News & Insight: November 13, 2014

November 13th 2014

The Invisible Revolution

November 11th 2014

How CTCs and Circulating Naked Tumor DNA-as Liquid Biopsies-Will Transform Diagnostic and Management of Oncology Patients

Should Physicians Friend or Unfriend Social Media? 'It's Complicated'

November 11th 2014

Compared to other industries, the medical profession has been late in recognizing the many benefits of social media. In the past few years, it has entered into an uneasy relationship with the new medium.

Side Effect Management With Regorafenib in mCRC

November 8th 2014

Second- and Third-Line Therapies in mCRC

November 8th 2014

Goals of Therapy in Metastatic CRC

November 8th 2014

Selecting First-line Treatment in mCRC

November 8th 2014

Latest News & Insight: November 7, 2014

November 8th 2014

CMS Earmarks $840 Million to Encourage Practice Transformation Networks

November 7th 2014

To help clinicians rethink and redesign their practices by moving from a model that is driven by quantity of care to one focused on patients' health outcomes, the Centers for Medicare & Medicaid Services (CMS) will earmark $840 million to improve health outcomes and reduce unnecessary hospitalization and other overutilization of services.

ODAC Votes Against Panobinostat in Multiple Myeloma

November 6th 2014

In what was described as a very difficult decision, ODAC voted 5-2 against the accelerated approval of the HDAC inhibitor panobinostat in combination with bortezomib and dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.

FDA Approves Ramucirumab Plus Paclitaxel for Advanced Gastric Cancer

November 5th 2014

The FDA has approved the combination of ramucirumab and paclitaxel as a treatment for patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.

CMS Finalizes 2015 Payment Schedule

November 4th 2014

This past Friday, the Centers for Medicare and Medicaid Services (CMS) released nearly 3,000 pages of regulations finalizing 2015 payment rates for various providers and services in the Medicare program, including physicians.

Reducing Lung Biopsies May Cut Costs, Improve Patient Outcomes

October 30th 2014

Biopsies were found to be the most costly tool used in lung cancer diagnosis, and may be performed too frequently based on negative test results and adverse events.

Financial Burden of Cancer Treatment Weighs Heavily on Patients

October 28th 2014

Nearly two-thirds of patients diagnosed with colorectal cancer report experiencing financial burden during their treatment, according to a study from the University of Michigan.

ICD-10 and Urologic Oncology: A Disappointing Combination

October 24th 2014

The 12-month countdown to the adoption of ICD-10 has begun. ICD-10 represents the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (usually referred to as "ICD"), now overseen by the World Health Organization (WHO).

As Hospitals Acquire Medical Practices, Cost of Patient Care Goes Up

October 24th 2014

Even as more hospitals seek to acquire medical groups and physician practices, this consolidation leads to higher expenditures through greater use of hospital-based ambulatory services, according to a recent study from the University of California, Berkeley School of Public Health.

Big Promise From Big Data

October 24th 2014

How can we slow down the growth of cancer costs and preserve-or better yet-enhance clinical outcomes?